Cappella Medical Devices

company

About

Cappella Medical Devices develops novel solutions for the treatment of complex coronary artery disease and bifurcation vascular disease.

  • 11 - 50

Details

Last Funding Type
Series D
Last Funding Money Raised
€10.50M
Industries
Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease.

The company was founded in 2004 by Antonio Columbo, M.D., Chief of Invasive Cardiology at San Raffaele Hospital in Milan, Italy, and Ascher Shmulewitz, M.D., Ph.D., a cardiologist, medical device entrepreneur and founder of NeoVision, Xcardia and Labcoat Ltd., and established its European headquarters in Galway in 2005.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€10.50M
Cappella Medical Devices has raised a total of €10.50M in funding over 2 rounds. Their latest funding was raised on Oct 28, 2010 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 28, 2010 Series D €10.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cappella Medical Devices is funded by 1 investors. Kreos Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kreos Capital Series D